Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

HINJ

HINJ’s ‘Value of Medical Innovation’ Portal Showcases How Life Sciences Is Saving Money — And Lives

New Brunswick, NJ, December 1, 2017 ― The HealthCare Institute of New Jersey (HINJ) continues to update its Value of Medical Innovation, a fact-driven, consumer-friendly digital library that delves into the myriad benefits of research-driven medical innovation, which saves money — and saves lives.

Introduced in September 2015, HINJ’s Value of Medical Innovation presents statistics from a number of resources, including the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. government sources and various medical research organizations. Continue reading

Mayors Committee on Life Sciences Patient Courage Award Presented to Ralph Wehmann in Alpine

(L. to r.) Ralph Wehmann, Alpine Mayor Paul Tomasko and Dean Paranicas

Alpine, NJ, November 28, 2017 —The Mayors Committee on Life Sciences on November 20 presented its Patient Courage Award to Alpine resident Ralph Wehmann, in recognition of his strength in the face of adversity and commitment to helping others.

The honor was presented by Dean J. Paranicas, who serves as President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ) and a Co-Chair of We Work for Health New Jersey, during the Alpine Mayor and Council meeting.

Mr. Wehmann’s battle with myelodysplastic syndrome (MDS) began in 2012. It was not his first brush with a life-threatening illness, so it came as no surprise to those that know him that he fought back with the same determination and positive spirit he had demonstrated previously. Continue reading

TODAY @ 5 PM: Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center to Host ‘Patient Perspectives’ in Research on November 16; Third in Forum Series

New Brunswick, NJ, November 16, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, November 16 for “The Patient’s Perspective: Emotional and Physical Benefits of Medical Devices,” the third in the Rutgers-HINJ Fall 2017 series of educational panels and seminars that focus on the medical device industry.

The event will be held from 4:30 to 7:00 p.m. (networking at 4:30 p.m.; program at 5:30 p.m.) at Rutgers University BME Auditorium (Busch Campus), 599 Taylor Road, Piscataway.

Scientists and engineers do amazing work creating innovative therapies and devices that enhance and save lives.  However, while working in a lab, there are few opportunities to see patients who benefit from the health care made possible by medical innovation.  Continue reading

Mayors Committee on Life Sciences Presents Patient Courage Award to David Dubin in Haworth

(L. to r.) Mayor John Smart, David Dubin and Dean Paranicas

Haworth, NJ, October 27, 2017 — During the Haworth Borough Council meeting on Tuesday night, the Mayors Committee on Life Sciences presented its Patient Courage Award to Haworth resident David Dubin, in recognition of his strength in the face of adversity and commitment to helping others.

The honor was presented by HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas, who serves as a Co-Chair of We Work for Health New Jersey.

Mr. Dubin has Lynch syndrome and is a three-time cancer survivor.  Lynch syndrome is caused by a genetic mutation that increases the risk for certain types of cancers.  He was first diagnosed with colon cancer in 1997 but did not undergo genetic testing until the cancer returned in 2007. Continue reading

VENDORS EVENT: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, October 25, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends in procurement and issues of importance to the industry. Continue reading

HINJ, PhRMA, Others Challenge NJ Attorney General’s Push to Limit Compensation to Prescribing Doctors

Dean J. Paranicas, President and Chief Executive Officer, HINJ

Trenton, NJ, October 23, 2017 — WHYY Public Radio Philadelphia’s Joe Hernandez reports that, in a new push to fight the opioid crisis, New Jersey officials are trying to stop the flow of legal but highly addictive painkillers at the source: doctors.

A proposed rule change by N.J. Attorney General Christopher Porrino would restrict the amount of money and other compensation drug companies can give out to doctors and other prescribers.  In doing so, state officials hope medical professionals will feel less pressure to prescribe opioids created and sold by the same companies that ply them with gifts and food.

But at a Thursday public hearing in Newark, representatives of the state’s pharmaceutical and medical industries criticized the potential rule change, questioning why it would apply to all drugs and claiming it would damage patient care and drive providers out of state. Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center to Host Cybersecurity for Medical Devices’ on October 19; Second in Forum Series

New Brunswick, NJ, October 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, October 19 for “Cybersecurity for Medical Devices: Why and How,” which is the second in their Fall 2017 series of educational panels and seminars that focus on the medical device industry.

The forum will be held from 5:00 to 7:00 p.m. at Rutgers University Easton Auditorium (Busch Campus), 101 Bevier Road, Piscataway.  A networking reception will begin at 5:00 p.m.; the program will start at 5:30 p.m.

Medical device vulnerability to cybercrime is increasing, creating threats that can result in hospital data theft, patient identity theft and potential harmful impact to medical device safety and effectiveness.  Continue reading

THURSDAY MORNING! Join HINJ for 2017 Life Sciences Celebration in Trenton; Six Honorees Named

New Brunswick, NJ, October 10, 2017 ― The HealthCare Institute of New Jersey (HINJ) will honor meritorious leadership in and contributions to New Jersey’s life sciences community at HINJ’s Life Sciences Celebration 2017, which will be held Thursday, October 12 from 8:00 to 10:00 a.m. at the Historic Trenton Masonic Temple, 100 Barrack Street, Trenton.

Online registration for the free event is now open.

HINJ’s 2017 honorees are: Continue reading

R&D Council of NJ Names 2017 Edison Patent and Special Recognition Honorees; Event Set for Nov. 2

Chatham, NJ, September 28, 2017 ― The Research & Development Council of New Jersey will present its 2017 Annual Edison Patent Awards on November 2 at the Liberty Science Center in Jersey City, NJ.

The 2017 Edison Patent Award winners — which include Merck & Co., Inc. and Johnson & Johnson subsidiary Ethicon, member companies of the HealthCare Institute of New Jersey (HINJ) — are:

  • Biomaterials: Rutgers, The State University of New Jersey
  • Biomedical: New Jersey Institute of Technology (NJIT)
  • Energy: Siemens Energy
  • Environmental: BASF
  • Imaging Systems: Princeton Plasma Physical Laboratory
  • Industrial Process: ExxonMobil
  • Information Technology: Avaya
  • Instrumentation: Stevens Institute of Technology
  • Materials: Honeywell
  • Medical: Ethicon
  • Pharmaceutical: Lexicon Pharmaceuticals
  • Pharmaceutical: Merck & Co., Inc.
  • Technology Transfer: Princeton University
  • Telecommunications: Nokia Bell Labs

Continue reading

HINJ Named Among ‘Best Lobbying Firms’ in NJBIZ’s First Readers Rankings Survey

New Brunswick, NJ, September 20, 2017 — The HealthCare Institute of New Jersey (HINJ) was among the New Jersey companies, organizations and universities named in NJBIZ’s inaugural “Readers Rankings” survey.

In a special supplement published with NJBIZ’s September 18 issue, HINJ was named as one of the “Best Lobbying Firms,” along with Gibbons PC, Princeton Public Affairs Group and Public Strategies Impact LLC, with which HINJ tied for #3.

HINJ member companies Johnson & Johnson and Merck & Co., along with Rutgers University, were reader-ranked as the “Best Life Sciences Companies.” Continue reading